Sydney Lupkin

Ozempic and Banjaro are for type 2 diabetes, and Wegovi and Zepbound are for obesity.

But the latest twist is that now there's a possibility of a pill.

Two pills, actually.

And to be clear, we're not talking about Rebelsis, which is a semaglutide pill, but it's approved for type 2 diabetes.

Got it.

Let's talk about the pill made by Novo Nordisk, whose active ingredient is semaglutide.

It's a peptide, a protein.

The problem is that in your stomach, the drug gets broken down too efficiently and too fast for the semaglutide to get into the bloodstream and do its job all over your body.

Andrea says to think about how your stomach breaks down some chicken that you've eaten.

Yeah, they added something to it.

I'll let Andrea explain it, but the gist is that this snack thing creates a little protective buffer zone around the pill to keep it from getting broken down too quickly and help it get absorbed into the bloodstream.

Then it can do all those other things to make you feel full and regulate blood sugar.

The catch is that you have to take this pill on an empty stomach and wait 30 minutes before eating anything else for it to work.

Yeah, I definitely heard from people who were like, pass.

The injection is working for me.

I'm good.

I don't want this.

But others were curious.

So that one is made by Eli Lilly, which makes the injectables Manjaro and Zepbound.

And they both share the same active ingredient called triazepatide.